Adam K. Stern
Director
Finance
Matinas Biopharma
United States of America
Biography
Mr. Stern has been Head of Private Equity Banking at Aegis Capital Corp. and CEO of SternAegis Ventures since 2012. Prior to Aegis, from 1997 to November 2012, he was with Spencer Trask Ventures, Inc., most recently as a Senior Managing Director, where he managed the structured finance group focusing primarily on the technology and life science sectors. Mr. Stern held increasingly responsible positions from 1989 to 1997 with Josephthal & Co., Inc., members of the New York Stock Exchange, where he served as Senior Vice President and Managing Director of Private Equity Marketing. He has been a FINRA licensed securities broker since 1987 and a General Securities Principal since 1991. Mr. Stern currently serves as a Director of Dance Biopharm, Inc. and is a former Director of InVivo Therapeutics Holdings Corp. (OTCQB: NVIV), Organovo Holdings, Inc. (NYSE MKT: ONVO) and PROLOR Biotech (formerly NYSE MKT: PBTH). Mr. Stern holds a Bachelor of Arts degree with honors from The University of South Florida in Tampa.
Research Interest
Business Management